These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 6173340

  • 1. Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part I - Antitumor antibiotics and their derivatives.
    Umezawa H.
    Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):12-8. PubMed ID: 6173340
    [Abstract] [Full Text] [Related]

  • 2. [New anthracycline antibiotics and derivatives].
    Tatsuta K.
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2640-52. PubMed ID: 6594977
    [Abstract] [Full Text] [Related]

  • 3. Experimental studies of new anthracyclines: aclacinomycin, THP-adriamycin and ditrisarubicins.
    Umezawa K, Kunimoto S, Takeuchi T.
    Biomed Pharmacother; 1987 Dec; 41(5):206-13. PubMed ID: 2444279
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Immunomodulation by antitumor antibiotics].
    Ishizuka M.
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):697-700. PubMed ID: 3963840
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Studies on the mechanism of drug resistance in tumor cells and a new antitumor antibiotic].
    Tanaka N.
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2666-73. PubMed ID: 6210060
    [Abstract] [Full Text] [Related]

  • 10. [Effects of aclacinomycin B on biological macromolecular contents and synthesis of L1210 cells].
    Li ZR, Feng JB, Liang F, Zeng SX, Han R.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Jun; 6(3):174-8. PubMed ID: 6241042
    [No Abstract] [Full Text] [Related]

  • 11. [Optimal administration schedules of antineoplastic antibiotics based on their pharmacokinetics, with special reference to bleomycins and anthracyclines].
    Ota K, Goto T, Fukushima M, Ariyoshi Y.
    Gan To Kagaku Ryoho; 1982 Aug; 9(8):1352-61. PubMed ID: 6191712
    [Abstract] [Full Text] [Related]

  • 12. Activity of (7) anthracycline related compounds in an doxorubicin sensitive human small cell lung cancer line and its doxorubicin resistant descendant. Activity of doxorubicin, daunorubicin, 4-deoxyrubicin, 4-demethoxydaunorubicin, detorubicin, 4'-epidoxorubicin and mitoxantrone.
    Zijlstra JG, Meijer C, Timmer-Bosscha H, Le TK, de Vries EG, Mulder NH.
    Eur J Respir Dis Suppl; 1987 Aug; 149():53-5. PubMed ID: 3034649
    [No Abstract] [Full Text] [Related]

  • 13. Pulmonary toxicity induced by pepleomycin 3-[(S)-1'-phenylethylamino] propylamino-bleomycin.
    Shinkai T, Saijo N, Tominaga K, Eguchi K, Shimizu E, Shibuya M, Shimabukuro Z, Koketsu H, Nakajima T, Niitani H.
    Jpn J Clin Oncol; 1983 Jun; 13(2):395-410. PubMed ID: 6193296
    [Abstract] [Full Text] [Related]

  • 14. Failure of aclacinomycin and 7-con-O-methylnogarol (7-OMEN) to decrease cardiac guanylate cyclase activity.
    Levey BA, Ruiz E, Rogerson B, Lehotay DC, Levey GS.
    Cancer Treat Rep; 1980 Jun; 64(10-11):1127-8. PubMed ID: 6109566
    [No Abstract] [Full Text] [Related]

  • 15. Antitumor antibiotics and low molecular weight immunomodifiers of microbial origin.
    Umezawa H.
    Cancer Treat Rep; 1984 Jan; 68(1):137-44. PubMed ID: 6692425
    [Abstract] [Full Text] [Related]

  • 16. Relative pulmonary toxicity and antitumor effects of two new bleomycin analogs, pepleomycin and tallysomycin A.
    Sikic BI, Siddik ZH, Gram TE.
    Cancer Treat Rep; 1980 Jan; 64(4-5):659-67. PubMed ID: 6159079
    [Abstract] [Full Text] [Related]

  • 17. Antitumor activity of new anthracycline antibiotics, aclacinomycin-A and its analogs, and their toxicity.
    Hori S, Shirai M, Hirano S, Oki T, Inui T, Tsukagoshi S, Ishizuka M, Takeuchi T, Umezawa H.
    Gan; 1977 Oct; 68(5):685-90. PubMed ID: 579346
    [Abstract] [Full Text] [Related]

  • 18. Preparation of 4- and 6-O-methyl-aclacinomycin derivatives and their antitumor activities.
    Tanaka H, Yoshioka T, Shimauchi Y, Matsushita Y, Matsuzawa Y, Oki T, Inui T.
    J Antibiot (Tokyo); 1981 Jul; 34(7):905-8. PubMed ID: 7287594
    [No Abstract] [Full Text] [Related]

  • 19. Mutagenicity of aclacinomycin A and daunomycin derivatives.
    Umezawa K, Sawamura M, Matsushima T, Sugimura T.
    Cancer Res; 1978 Jun; 38(6):1782-4. PubMed ID: 348304
    [Abstract] [Full Text] [Related]

  • 20. [Study of new antineoplastic antibiotics based on newly discovered action mechanisms].
    Tanaka N.
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1094-106. PubMed ID: 6191673
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.